All Posts
Monthly Scientific Update – February 2023
LCK Inhibitor: A Novel Potential Therapy for Cholangiocarcinoma A variety of signaling pathways can become overactive in cancer to promote…
Cholangiocarcinoma Awareness Month
February is Cholangiocarcinoma Awareness Month. The Cholangiocarcinoma Foundation (CCF) invites the community to help educate the public about bile duct…
Monthly Scientific Update – January 2023
Apigenin-Conjugated Gold Nanoparticles: A Potential New Treatment for Cholangiocarcinoma Apigenin is a plant-derived compound that has been explored as a…
Bruce Coppock, Former Vice Chair of the Board of Directors of the Cholangiocarcinoma Foundation, Dies at age 71
Cholangiocarcinoma patient Bruce Coppock leaves behind a legacy of leadership benefiting the Cholangiocarcinoma Foundation Bruce Coppock, Vice Chair of the…
Monthly Scientific Update – December 2022
The Oral Microbiome in Cholangiocarcinoma: A Potential Biomarker that Could Promote Early Detection Kelly Butler, Dr. Reham Abdel-Wahab The human…
Learning to say goodbye
For me, the most challenging part of cholangiocarcinoma was not all the chemo and disruption but dealing with my mortality.…
CCF's Discussion Board
Dear Friends, On October 12, 2005, my brother was diagnosed with cholangiocarcinoma. Thus began a journey I could not have…
Monthly Scientific Update – November 2022 (A recent study investigated the effects of PD-L1 expression on cancer cells and tumor-infiltrating immune cells in intrahepatic cholangiocarcinoma (CCA))
PD-L1 on Tumor-Infiltrating Immune Cells: A Potential Prognostic Biomarker for Cholangiocarcinoma Kelly Butler, Dr. Reham Abdel-Wahab Patients may develop cancer…
‘Think tank’ of multidisciplinary experts develop proposals to leverage precision medicine in improving cholangiocarcinoma patient outcomes
Cholangiocarcinoma Foundation sponsored C2T2 in Las Vegas with funding from a generous donor Twenty-nine expert scientists and clinicians from the…
Cure Cholangiocarcinoma Think Tank (C2T2)
The Cholangiocarcinoma Foundation has published a white paper from the first Cure Cholangiocarcinoma Think Tank (C2T2 ) meeting, which gathered…